![Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors | Journal of Medicinal Chemistry Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01180/asset/images/large/jm1c01180_0001.jpeg)
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors | Journal of Medicinal Chemistry
![International Master in Neuroscience's students visit Lek-Novartis | Università degli studi di Trieste International Master in Neuroscience's students visit Lek-Novartis | Università degli studi di Trieste](https://www.units.it/sites/default/files/styles/colorbox_image/public/media/immagini/notizie/img_3984a.jpg?itok=REdVESPK)
International Master in Neuroscience's students visit Lek-Novartis | Università degli studi di Trieste
![Risultati finanziari 2021: Novartis triplica l'utile. Roche fatturato in crescita, ma reddito netto cala (-1%) - AboutPharma Risultati finanziari 2021: Novartis triplica l'utile. Roche fatturato in crescita, ma reddito netto cala (-1%) - AboutPharma](https://www.aboutpharma.com/wp-content/uploads/2022/02/finanza-e1643905322347.jpg)
Risultati finanziari 2021: Novartis triplica l'utile. Roche fatturato in crescita, ma reddito netto cala (-1%) - AboutPharma
![Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. - Abstract - Europe PMC Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5601375/bin/ml-2017-002936_0006.jpg)
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. - Abstract - Europe PMC
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuv
![Cambio ai vertici di Novartis Italia: Valentino Confalone è il nuovo country president - AboutPharma Cambio ai vertici di Novartis Italia: Valentino Confalone è il nuovo country president - AboutPharma](http://www.aboutpharma.com/wp-content/uploads/2022/06/Valentino-Confalone-002-scaled-e1654087206647.jpg)